The rationale for glutamate antagonists in the treatment of traumatic brain injury

被引:21
作者
Myseros, JS
Bullock, R
机构
[1] Division of Neurosurgery, Richmond, Virginia, 23298-0631
来源
NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS | 1995年 / 765卷
关键词
D O I
10.1111/j.1749-6632.1995.tb16583.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:262 / 271
页数:10
相关论文
共 44 条
[41]   MORALS, REASON AND ANIMALS - SAPONTZIS,SF [J].
SMITH, JA .
JOURNAL OF MEDICAL ETHICS, 1991, 17 (03) :167-167
[42]   SUBDURAL HEMATOMAS .1. ACUTE SUBDURAL-HEMATOMA - PROGRESS IN DEFINITION, CLINICAL PATHOLOGY, AND THERAPY [J].
STONE, JL ;
RIFAI, MHS ;
SUGAR, O ;
LANG, RGR ;
OLDERSHAW, JB ;
MOODY, RA .
SURGICAL NEUROLOGY, 1983, 19 (03) :216-231
[43]   THE EFFECTS OF A COMPETITIVE NMDA RECEPTOR ANTAGONIST (CGS-19755) ON CEREBRAL BLOOD-FLOW AND PH IN FOCAL ISCHEMIA [J].
TAKIZAWA, S ;
HOGAN, M ;
HAKIM, AM .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (05) :786-793
[44]   AUTORADIOGRAPHIC ANALYSIS OF H-3 MK-801 (DIZOCILPINE) INVIVO UPTAKE AND INVITRO BINDING AFTER FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
WALLACE, MC ;
TEASDALE, GM ;
MCCULLOCH, J .
JOURNAL OF NEUROSURGERY, 1992, 76 (01) :127-133